Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.004 | 1 |
mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.00092 | 1 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |